← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2004Last known activity
Dec 31, 2025
Timeline
1950s
- Jan 1, 1951
Blokhin's Russian Cancer Research Center— Founded
Drugs by trial phase (33 distinct, 19 trials)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Diseases
- Anus Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Digestive System Neoplasms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Gastrointestinal Neoplasms
- Glioblastoma
- Lung Neoplasms
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Neoplasms, Squamous Cell
- Rectal Neoplasms
- Stomach Neoplasms
- Vomiting
Recent trials (32)
- NCT07281001Lead sponsorN/ADec 31, 2025
- NCT07107217Lead sponsorPhase 2Aug 31, 2025
- NCT06978400OfficialPhase 2Mar 1, 2025
- NCT06967155Lead sponsorPhase 2Mar 1, 2025
- NCT06967155OfficialPhase 2Mar 1, 2025
- NCT06978400Lead sponsorPhase 2Mar 1, 2025
- NCT06428487Sponsor investigatorPhase 2Mar 31, 2022
- NCT06428487Lead sponsorPhase 2Mar 31, 2022
- NCT05057130Lead sponsorPhase 2/Phase 3Dec 31, 2021
- NCT04393584Overall official - principal investigatorPhase 2/Phase 3May 30, 2020
- NCT04393584Lead sponsorPhase 2/Phase 3May 30, 2020
- NCT04442984Lead sponsorPhase 2Nov 3, 2019
- NCT04135313Reponsible party - principal investigatorPhase 3Oct 20, 2019
- NCT04135313Lead sponsorPhase 3Oct 20, 2019
- NCT04135313Overall official - principal investigatorPhase 3Oct 20, 2019
Details
- Founded
- Moscow, RU Jan 1, 1951
- Last known activity
- Dec 31, 2025